Rosetta Genomics Ltd. (ROSGQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Feb 21, 2025, 3:00 PM EST
Rosetta Genomics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | 2011 - 2007 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '17 Jun 30, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | 2011 - 2007 |
| Revenue | 2.86 | 2.04 | 2.88 | 1.33 | 0.41 | 0.2 | Upgrade
|
| Revenue Growth (YoY) | 106.43% | -29.08% | 116.65% | 227.65% | 101.49% | 95.15% | Upgrade
|
| Cost of Revenue | 1.9 | 1.54 | 1 | 1.31 | 0.71 | 0.26 | Upgrade
|
| Gross Profit | 0.96 | 0.5 | 1.87 | 0.02 | -0.3 | -0.06 | Upgrade
|
| Selling, General & Admin | 8.67 | 9.98 | 12.02 | 12.34 | 11.3 | 6.96 | Upgrade
|
| Research & Development | 2.89 | 3.16 | 2.96 | 1.93 | 1.74 | 1.25 | Upgrade
|
| Operating Expenses | 11.56 | 13.13 | 14.97 | 14.27 | 13.04 | 8.21 | Upgrade
|
| Operating Income | -10.59 | -12.64 | -13.1 | -14.25 | -13.35 | -8.27 | Upgrade
|
| Interest Expense | -0.69 | -0.6 | -0.59 | -0.04 | -0.02 | -1.84 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | 0.05 | 0.11 | 0.15 | 0.04 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.01 | -0.01 | 0.01 | -0.41 | -0.01 | 0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.73 | 0.01 | -1.05 | 0.08 | 0.06 | -0.67 | Upgrade
|
| EBT Excluding Unusual Items | -9.53 | -13.22 | -14.68 | -14.51 | -13.17 | -10.7 | Upgrade
|
| Impairment of Goodwill | - | - | 0.16 | - | - | - | Upgrade
|
| Pretax Income | -9.53 | -13.22 | -14.53 | -14.51 | -13.17 | -10.7 | Upgrade
|
| Income Tax Expense | -0.05 | -0.03 | 0.02 | 0.02 | - | - | Upgrade
|
| Earnings From Continuing Operations | -9.48 | -13.18 | -14.55 | -14.53 | -13.17 | -10.7 | Upgrade
|
| Earnings From Discontinued Operations | -3.91 | -3.05 | -2.8 | - | 0.27 | 0.24 | Upgrade
|
| Net Income | -13.39 | -16.23 | -17.35 | -14.53 | -12.9 | -10.46 | Upgrade
|
| Net Income to Common | -13.39 | -16.23 | -17.35 | -14.53 | -12.9 | -10.46 | Upgrade
|
| Shares Outstanding (Basic) | 2 | 2 | 1 | 1 | 1 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 2 | 1 | 1 | 1 | 0 | Upgrade
|
| Shares Change (YoY) | 34.34% | 46.51% | 34.28% | 17.16% | 115.67% | 776.33% | Upgrade
|
| EPS (Basic) | -6.41 | -8.81 | -13.79 | -15.51 | -16.13 | -28.21 | Upgrade
|
| EPS (Diluted) | -6.41 | -8.81 | -13.79 | -15.51 | -16.13 | -28.21 | Upgrade
|
| Free Cash Flow | -11.73 | -10.7 | -17.05 | -13.85 | -11.23 | -8.91 | Upgrade
|
| Free Cash Flow Per Share | -5.61 | -5.81 | -13.56 | -14.79 | -14.05 | -24.03 | Upgrade
|
| Gross Margin | 33.65% | 24.42% | 65.11% | 1.28% | -75.06% | -28.36% | Upgrade
|
| Operating Margin | -370.55% | -619.67% | -455.62% | -1074.00% | -3295.56% | -4112.94% | Upgrade
|
| Profit Margin | -468.35% | -796.13% | -603.30% | -1094.65% | -3184.44% | -5202.49% | Upgrade
|
| Free Cash Flow Margin | -410.21% | -524.96% | -593.04% | -1043.63% | -2773.83% | -4431.34% | Upgrade
|
| EBITDA | -10.35 | -12.37 | -12.8 | -13.95 | -13.05 | -7.99 | Upgrade
|
| D&A For EBITDA | 0.24 | 0.27 | 0.3 | 0.3 | 0.3 | 0.27 | Upgrade
|
| EBIT | -10.59 | -12.64 | -13.1 | -14.25 | -13.35 | -8.27 | Upgrade
|
| Revenue as Reported | 2.04 | 2.04 | 2.88 | 1.33 | 0.41 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.